COST-EFFECTIVENESS STUDY OF THE USE OF PORTABLE COAGULOMETERS FOR THE INR CONTROL, IN COMPARISON WITH HOSPITAL CARE, IN PATIENTS WITH COAGULATION DISORDERS, UNDER THE CONTEXT OF THE MEXICAN PUBLIC HEALTH SETTING

被引：0
|
作者：
Bautista, J. [1 ]
Reyes-Loredo, J. [2 ]
Cachoeira, C. [3 ]
Gay Molina, J. G. [4 ]
机构：
[1] Roche Diagnost Mexico, Mexico City, DF, Mexico
[2] Roche, Mexico City, DF, Mexico
[3] Roche Brazil, Sao Paulo, Brazil
[4] TI Salud, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2529
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMD24
引用
收藏
页码：A867 / A867
页数：1
相关论文
共 13 条
  • [1] COST-EFFECTIVENESS OF MYCOPHELONATE SODIUM ON PATIENTS WITH RENAL TRANSPLANT AT THE PUBLIC MEXICAN HEALTH CARE SYSTEM
    Miranda, Ruiz C., I
    Lopez, Ubiarco, V
    VALUE IN HEALTH, 2014, 17 (07) : A469 - A470
  • [2] COST-EFFECTIVENESS OF RANIBIZUMAB ON PATIENTS WITH DIFFUSE DIABETIC MACULAR EDEMA WITHIN THE PUBLIC MEXICAN HEALTH CARE SYSTEM
    Miranda, Ruiz C., I
    Lopez, Ubiarco, V
    VALUE IN HEALTH, 2014, 17 (07) : A607 - A607
  • [3] COST-EFFECTIVENESS OF INDACATEROL ON PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AT THE PUBLIC MEXICAN HEALTH CARE SYSTEM
    Reyes-lopez, A.
    Lemus-Carmona, E. A.
    Orozco, E.
    VALUE IN HEALTH, 2012, 15 (04) : A55 - A55
  • [4] COST-EFFECTIVENESS STUDY OF THE USE OF FIBRINOGEN CONCENTRATE (CLOTTAFACT®) IN PATIENTS WITH MAJOR BLEEDING AND TRAUMA REQUIRING SURGERY IN MEXICAN PUBLIC HEALTH INSTITUTIONS
    Gay Molina, J.
    Valls, M.
    Morales, E.
    Grimaldi, A.
    Delgado, J.
    VALUE IN HEALTH, 2024, 27 (06) : S142 - S143
  • [5] COST-EFFECTIVENESS ANALYSIS OF THE USE OF MICROINVASIVE SURGERY WITH ISTENT® IN COMBINATION WITH PHACOEMUSIFICATION FOR GLAUCOMA AND CATARACT PATIENTS IN THE MEXICAN PUBLIC HEALTH SYSTEM.
    Gay, J. G.
    Valls, M.
    Osorio, M.
    Torres, J.
    VALUE IN HEALTH, 2019, 22 : S671 - S671
  • [6] HOSPITAL VERSUS HOME CARE FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES IN CURATIVE OR TERMINAL PHASE: USE OF THE RESOURCES ANALYSIS, SYMPTOM BURDEN AND COST-EFFECTIVENESS STUDY
    Cartoni, C.
    Tendas, A.
    Efficace, F.
    Niscola, P.
    Soldati, S.
    Brunetti, G. A.
    Meloni, E.
    Minotti, C.
    Cupelli, L.
    Marini, M. G.
    Reale, L.
    Martone, N.
    Foa, R.
    Alimena, G.
    de Fabritiis, P.
    Mandelli, F.
    HAEMATOLOGICA, 2015, 100 : 24 - 24
  • [7] COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE VERSUS WARFARIN FOR STROKE PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION UNDER THE PRIVATE AND PUBLIC HEALTH CARE SYSTEM IN BRAZIL
    Nasciben, V
    Figueiredo, M. J. D. O.
    Darrieux, F. C. D. C.
    Piegas, L. S. P.
    Martins, S. C. O.
    VALUE IN HEALTH, 2012, 15 (04) : A122 - A122
  • [8] LONG-TERM COST-EFFECTIVENESS ANALYSIS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) FROM A MEXICAN PUBLIC AND PRIVATE HEALTH CARE PERSPECTIVE BASED ON DATA FROM THE PLATO TRIAL
    Garcia-Castillo, A.
    De-los-Rios, M.
    Polanco, A. C.
    Ramirez, M. A.
    Nikolic, E.
    Mellstrom, C.
    VALUE IN HEALTH, 2011, 14 (07) : A379 - A380
  • [9] COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE VERSUS ACETYLSALICILIC ACID FOR STROKE PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION UNDER THE PRIVATE AND PUBLIC HEALTH CARE SYSTEM IN BRAZIL
    Nasciben, V
    Figueiredo, M. J. D. O.
    Martins, S. C. O.
    Piegas, L. S. P.
    VALUE IN HEALTH, 2012, 15 (04) : A120 - A120
  • [10] COST-EFFECTIVENESS OF DABIGATRAN VERSUS FACTOR XA INHIBITORS FOR STROKE PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION UNDER THE PRIVATE AND PUBLIC HEALTH CARE SYSTEM IN BRAZIL
    Santoni, N. B.
    Melo, T. G.
    Almeida, E. P.
    VALUE IN HEALTH, 2014, 17 (03) : A113 - A113
12